ARTICLE | Emerging Company Profile
Getting past PTSD
How Neurovation’s GRIA1 programs could improve PTSD diagnosis and treatment
June 21, 2018 6:29 PM UTC
Neurovation Labs Inc. is developing a GRIA1-targeting tracer and a small molecule therapy that could provide an objective diagnosis of PTSD and treat the underlying disease instead of just its symptoms.
Post-traumatic stress disorder (PTSD) is diagnosed with a symptom checklist that is typically self-reported and therefore not objective. ...
BCIQ Target Profiles